FRIDAY, May 19, 2023 (HealthDay News) — Patients with Crohn’s disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib). Rinvoq is meant to treat adults with moderately to severely active Crohn’s disease who have not had success with TNF (tumorContinue Reading

WEDNESDAY, May 17, 2023 (HealthDay News) — Skip artificial sweeteners if you’re trying to lose weight, warns the World Health Organization (WHO), noting the sugar substitutes aren’t effective for shedding pounds and may also cause harm. Long-term use of sugar substitutes may cause “potential undesirable effects,” according to new WHOContinue Reading

WEDNESDAY, May 17, 2023 (HealthDay News) — Kids whose families left distressed neighborhoods had significantly fewer severe asthma attacks, with improvements greater even than those seen with medication. New research found that children whose families participated in a program that enabled them to move to areas with less poverty, andContinue Reading